关注
Louis van der Putten
Louis van der Putten
未知所在单位机构
在 radboudumc.nl 的电子邮件经过验证
标题
引用次数
引用次数
年份
L1CAM expression in endometrial carcinomas: an ENITEC collaboration study
LJM Van Der Putten, N Visser, K Van de Vijver, M Santacana, P Bronsert, ...
British journal of cancer 115 (6), 716-724, 2016
1152016
Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study
C Reijnen, E Gogou, NCM Visser, H Engerud, J Ramjith, ...
PLoS medicine 17 (5), e1003111, 2020
642020
Added value of estrogen receptor, progesterone receptor, and L1 cell adhesion molecule expression to histology-based endometrial carcinoma recurrence prediction models: an …
LJM Van Der Putten, NCM Visser, K Van de Vijver, M Santacana, ...
International Journal of Gynecologic Cancer 28 (3), 2018
632018
Neoadjuvant chemotherapy followed by surgery for advanced-stage endometrial cancer
NM De Lange, NPM Ezendam, JS Kwon, I Vandenput, D Mirchandani, ...
Current Oncology 26 (2), e226, 2019
482019
Molecular profiles of benign and (pre) malignant endometrial lesions
LJM van der Putten, R van Hoof, BBJ Tops, MPLM Snijders, ...
Carcinogenesis 38 (3), 329-335, 2017
452017
The role of adjuvant therapy in stage IA serous and clear cell uterine cancer: A multi-institutional pooled analysis
XM Qu, VM Velker, E Leung, JS Kwon, MA Elshaikh, I Kong, NA Logie, ...
Gynecologic oncology 149 (2), 283-290, 2018
362018
Diagnostic accuracy of endometrial biopsy in relation to the amount of tissue
C Reijnen, NCM Visser, J Bulten, LFAG Massuger, LJM van der Putten, ...
Journal of clinical pathology 70 (11), 941-946, 2017
352017
Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer
SW Vrede, WJ Van Weelden, NCM Visser, J Bulten, LJM Van Der Putten, ...
Gynecologic oncology 161 (3), 787-794, 2021
342021
Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium
YP Geels, LJM Van Der Putten, AAG Van Tilborg, I Lurkin, EC Zwarthoff, ...
Gynecologic oncology 137 (2), 245-251, 2015
312015
Mutational analysis of cervical cytology improves diagnosis of endometrial cancer: A prospective multicentre cohort study
C Reijnen, LJM van der Putten, J Bulten, MPLM Snijders, ...
International Journal of Cancer 146 (9), 2628-2635, 2020
282020
Oestrogen receptor pathway activity is associated with outcome in endometrial cancer
WJ van Weelden, LJM van der Putten, MA Inda, A van Brussel, ...
British journal of cancer 123 (5), 785-792, 2020
262020
Reproducibility of measurement of myometrial invasion in endometrial carcinoma
LJM van der Putten, K Van de Vijver, C Bartosch, B Davidson, S Gatius, ...
Virchows Archiv 470, 63-68, 2017
252017
Population-based treatment and outcomes of stage I uterine serous carcinoma
LJM van der Putten, P Hoskins, A Tinker, P Lim, C Aquino-Parsons, ...
Gynecologic oncology 132 (1), 61-64, 2014
232014
Relevance of molecular profiling in patients with low-grade endometrial cancer
SW Vrede, J Kasius, J Bulten, S Teerenstra, J Huvila, E Colas, ...
JAMA network open 5 (12), e2247372-e2247372, 2022
172022
Lymphovascular space invasion and the treatment of stage I endometrioid endometrial cancer
LJM van der Putten, YP Geels, NPM Ezendam, HWHM van der Putten, ...
International Journal of Gynecologic Cancer 25 (1), 2015
142015
Immunohistochemical profiles of endometrioid endometrial carcinomas with and without metastatic disease
YP Geels, LJM van der Putten, AAG van Tilborg, BEC Nienhaus, ...
Applied Immunohistochemistry & Molecular Morphology 26 (3), 173-179, 2018
132018
Addition of IMP3 to L1CAM for discrimination between low-and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer …
NCM Visser, LJM van der Putten, A van Egerschot, KK Van de Vijver, ...
Human pathology 89, 90-98, 2019
72019
Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancer
MHD van Bommel, JMA Pijnenborg, LJM van der Putten, J Bulten, ...
International Journal of Gynecologic Cancer 32 (12), 2022
42022
Development and validation of an endometrial carcinoma preoperative Bayesian network using molecular and clinical biomarkers (ENDORISK): An ENITEC collaboration study
C Reijnen, E Gogou, L van der Putten, N Visser, K Van de Vijver, ...
International Journal of Gynecologic Cancer 29 (Suppl 4), 2019
32019
The opinion of gynecologists on the management of early-stage, high-grade endometrioid endometrial cancer
YP Geels, LJM van der Putten, EM van der Steen-Banasik, M Snijders, ...
Eur J Gynaecol Oncol 36 (4), 402-405, 2015
32015
系统目前无法执行此操作,请稍后再试。
文章 1–20